Lymphoma Hub (@lymphomahub) 's Twitter Profile
Lymphoma Hub

@lymphomahub

A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) linktr.ee/Lymphoma #lymsm

ID: 1582593798

linkhttp://www.lymphomahub.com calendar_today10-07-2013 08:56:22

10,10K Tweet

9,9K Followers

2,2K Following

Lymphoma Hub (@lymphomahub) 's Twitter Profile Photo

CONGRESS | #SOHO2024 Jason Westin Jason Westin, MD FACP MD Anderson Cancer Center shares data from the phase Ib trial of GOLCA+R-CHOP as 1L therapy in aggressive B-cell #lymphoma. ORR 0.2mg 82% and 0.4mg 88%, uMRD 0.2mg 73% and 0.4mg 90%, median DoR NR in either group, 12-mo PFS 0.4mg 85%, 120-mo

CONGRESS | #SOHO2024
Jason Westin <a href="/Lymphoma_Doc/">Jason Westin, MD FACP</a> <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> shares data from the phase Ib trial of GOLCA+R-CHOP as 1L therapy in aggressive B-cell #lymphoma. ORR 0.2mg 82% and 0.4mg 88%, uMRD 0.2mg 73% and 0.4mg 90%, median DoR NR in either group, 12-mo PFS 0.4mg 85%, 120-mo